SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 66.79   -6.13 (-8.41%) Volume: 745.86k 4:00 PM EDT 27-Mar-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities101/14/2019
4Statement of changes in beneficial ownership of securities101/14/2019
4Statement of changes in beneficial ownership of securities112/17/2018
8-KCurrent report pursuant to Section 13 or 15(d)212/18/2018
4Statement of changes in beneficial ownership of securities112/12/2018
8-K/A[Amend]Current report pursuant to Section 13 or 15(d)212/06/2018
8-KCurrent report pursuant to Section 13 or 15(d)211/13/2018
SC 13D/A[Amend] General statement of acquisition of beneficial ownership1011/13/2018
8-KCurrent report pursuant to Section 13 or 15(d)1411/08/2018
10-QGeneral form for quarterly reports under Section 13 or 15(d)4811/08/2018
4Statement of changes in beneficial ownership of securities110/25/2018
4Statement of changes in beneficial ownership of securities110/15/2018
4Statement of changes in beneficial ownership of securities110/12/2018
8-KCurrent report pursuant to Section 13 or 15(d)310/10/2018
4Statement of changes in beneficial ownership of securities110/09/2018
123456789101112131415